ECM
ATRA icon

ExodusPoint Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

ExodusPoint Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,467
Closed -$720K – 1463
2023
Q3 		$720K Buy
19,467
+2,752
+16% +$122K 0.01% 1098
2023
Q2 		$673K Buy
16,715
+5,776
+53% +$327K 0.01% 1247
2023
Q1 		$793K Buy
10,939
+8,489
+346% +$823K 0.01% 1219
2022
Q4 		$201K Buy
2,450
+52
+2% +$5.42K ﹤0.01% 1459
2022
Q3 		$227K Buy
+2,398
New +$269K ﹤0.01% 1604
2021
Q3 		– Sell
-498
Closed -$193K – 2099
2021
Q2 		$193K Buy
+498
New +$178K ﹤0.01% 1997
2021
Q1 		– Sell
-1,110
Closed -$545K – 2108
2020
Q4 		$545K Buy
+1,110
New +$512K 0.01% 1191
2020
Q1 		– Sell
-498
Closed -$205K – 1076
2019
Q4 		$205K Buy
+498
New +$172K ﹤0.01% 1332

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return